|
Download Program (PDF)
| Zeit | Vorträge |
09:00 - 09:15 | Opening Comments |
09:15 - 11:30 | Chair: Maria Neumann-Fraune/ Stefan Reuter |
| Prevalence and characteristics of Hepatitis B and C in HIV-infected patients from the RESINA cohort |
| Analysis of HBV resistant mutants by phenotypic assay |
| HBV Antiviral Drug Resistance |
| geno2pheno[hbv] - A Web Service for HBV Drug Resistance Analysis |
11:30 - 11:45 | Coffee break |
11:45 - 13:30 | Chair: Ulrich Spengler / Ulrike Protzer |
| BI 201335, a NS3/4A Serine Protease Inhibitor, and BI 207127, a NNI NS5b Polymerase Inhibitor for treatment of chronic HCV infection |
| |
| What is to be expected from new antivirals against Hepatitis C? A clinician.s perspective. |
| The Future in Hepatitis C Treatment: Therapy Individualization and STAT-C |
| Hepatitis C Virus: Basics |
13:30 - 14:30 | Lunch |
14:30 - 16:45 | Chair: Lutz Gürtler / Martin Däumer |
| Heavy cross: how to compare 454 data from virus populations? |
| How less is enough? |
| A Tool for Predicting the Success of First-Line Antiretroviral Therapies |
| HIV-GRADE Update 2010 and outlook |
| Free energy calculations on HIV-PR drug complexes |
| HIV-GRADE |
16:45 - 17:00 | Coffee break |
17:00 - 18:30 | Chair: Susanna Trapp/ Thomas Harrer |
| HIV-2 Resistance to Antiretroviral Drugs |
| COMET: A Novel approach to HIV-1 subtype prediction |
| HIV-2 Resistance Interpretation and Update of Case Report |
| HLA alleles in the context of RAMs in therapy naive patients |
| Etravirine Resistance Mutations and Immune selection |
| Transmission of Human Immunodeficiency Virus I Drug Resistance - A Case Report. |
| HIV gag mutations: Every little helps |
| Zeit | Vorträge |
09:00 - 09:15 | Patient view |
09:15 - 11:30 | Chair: Francesca Incardona, Thomas Lengauer |
| |
| HIV treatment & ARV resistance issues in India |
| HIV-1 drug resistance in Greece |
11:30 - 11:45 | Coffee break |
11:45 - 13:30 | Chair: Maurizio Zazzi, Eugen Schülter |
| |
| The CompNet resistance module: Current status |
| RegaDB |
| SnoB - INI-resistance in non-B Subtypes |
| Patient- and Drug-specific Models for HIV Cell Entry |
13:30 - 14:30 | Lunch |
14:30 - 16:45 | Chair: Carlo Perno, Herbert Pfister |
| HIV Eradication by Stem Cell Transplantation: Is It Feasible? |
| geno2pheno[454] - Coreceptor usage prediction with massively parallel sequencing |
| Comparative HIV-1 tropism study using Trofile and geno2pheno[coreceptor] of 61 clinical samples |
| TROPISM DETERMINATION IN BELGIUM |
| The Berlin Maraviroc cohort |
| Use of a genotypic assay for the prediction of HIV-1 co-receptor tropism and guiding the use of CCR5 antagonists in clinical practice |
| Genotypic Prediction of HIV-1 Coreceptor Usage and Application to Deep Sequencing |
| Coreceptor analysis - Current state in Germany and Europe |
16:45 - 17:00 | Coffee break |
17:00 - 18:00 | Chair: Patrick Braun, Alexander Thielen |
| European Guidelines on HIV-1 tropism testing |
| Contribution of Hans-Jürgen Stellbrink ICH Hamburg Schriftführer Deutsche AIDS- Gesellschaft |
| EU resistance guidelines v.2009 |
18:00 - 18:30 | Chair: Rolf Kaiser |
Download Program (PDF)